News

Pharmaceutical Technology48m
J&J eyes prostate cancer label expansion for Akeega
J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.
TheJournal.ie on MSN55m
Ursula von der Leyen to plead her case to MEPs ahead of a no-confidence vote
EUROPEAN COMMISSION PRESIDENT Ursula von der Leyen is set to travel to Strasbourg, France today to address MEPs before a ...